Skip to main content

Table 3 Patient characteristics for the bladder cancer patients included in the discovery and hematuria urine series

From: BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients

 

BlCa cases, discovery series (n = 26)

BlCa cases, hematuria series (n = 93)

Gender

Male

65% (17/26)

78% (73/93)

Female

35% (9/26)

22% (20/93)

Median age, yr (range)

75 (49–93)

69 (48–91)

Stage (n)

Ta

11

43

Ta + CIS

1

T1

22

T1 + CIS

9

T2

3

8

T2 + CIS

1

1

T3

2

1

T3 + CIS

2

T4

1

2

CIS

5

7

Grade

Low-grade

31% (8/26)

31% (29/93)*

High-grade

69% (18/26)

66% (61/93)*

  1. BlCa Bladder cancer; yr Year
  2. *Grade is missing for three of the patients